Himalaya Therapeutics, an India-based clinical-stage biopharmaceutical company, announced on Monday that it has named Brian Zhang, PhD as its new chief executive officer.
Dr Zhang has served Hoffmann-La Roche. He cofounded several biotechnology start-ups and invested in biopharmaceuticals.
Dr Zhang holds a PhD from UCLA School of Medicine and a BS from Nanjing University.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation